The invention is of a topical medicament and associated methodology for use thereof, through the use of which Peyronie's disease may be effectively, cost effectively, and painlessly treated. The primary active ingredient is a calmodulin blocker, the preferred such ingredient being trifluroperizine.

L'invention est d'un médicament topique et la méthodologie associée pour l'usage en, par l'utilisation dont la maladie de Peyronie peut être efficacement, a coûté efficacement, et sans douleur traité. La substance active primaire est un dresseur de calmoduline, préféré un tel ingrédient étant trifluroperizine.

 
Web www.patentalert.com

< Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained

< Stabilized liquid polypeptide-containing pharmaceutical compositions

> Immunoeffector compounds

> Removing or increasing permeability of embryonic capsule to prepare equine embryos for cryopreservation

~ 00062